Reports

As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Retinitis Pigmentosa Treatment Market: By Type: Autosomal Recessive RP, Autosomal Dominant RP, X-Linked RP; By Treatment: Drug, Device, Surgery, Others; By Distribution Channel; By End Use; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics; Competitive Landscape; Events and Developments

Global Retinitis Pigmentosa Treatment Market Outlook

The global retinitis pigmentosa treatment market is being driven by the growth of the retinal disorder treatment market. The global retinal disorder treatment market is expected to grow at a CAGR of 7% in the forecast period of 2020-2025 to reach a value of USD 15.4 billion by 2025.

 

Retinitis Pigmentosa Treatment Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The Asia Pacific Region to Witness the Fastest Growth in the Retinitis Pigmentosa Treatment Industry, Owing to a Large Patient Pool

The market for retinitis pigmentosa is supported by the large share of the market from the North America and Europe region collectively. This can be attributed to the upcoming approvals, and a surge in the number of research and awareness regarding the disorder, greater affordability, rise in product offerings, and an increase in demand for early treatment. The trend is expected to persist in the forecast period as well. The Asia Pacific region is expected to accelerate at a high rate over the forecast period. The region is governed by factors, such as the rise in the adoption of new products, large patient pool, and an increase in the demand for retinitis pigmentosa treatment in the emerging economies, like India and China. The market is also positively influenced by the inflating disposable incomes, changing lifestyles, and rapid urbanisation.

 

Retinitis Pigmentosa Treatment Market by End Use

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Retinitis Pigmentosa Treatment: Industry Definition and Segmentation

Retinitis pigmentosa treatment refers to the treatment of retinitis pigmentosa, which is a group of rare genetic disorders, which entail the breakdown and loss of cells in the retina. Common symptoms of retinitis pigmentosa include problems in seeing at night and a loss of peripheral vision.

On the basis of type, the market is divided into:

  • Autosomal Recessive RP
  • Autosomal Dominant RP
  • X-Linked RP

Based on treatment, the industry can be segmented into:

  • Drug
  • Device
  • Surgery

Drug is divided on the basis of type into vitamin A palmitate and acetazolamide, among others. Device is further divided on the basis of type into sunglasses, implants, and others. Surgery is divided on the basis of type into retinal transplantation and corneal neurotization, among others.

On the basis of distribution channel, the industry is categorised into:

  • Hospital Retailer
  • Retail Retailer
  • Online

Based on end use, the industry is segmented into:

  • Hospitals
  • Special Clinics
  • Home Care
  • Ophthalmologist
  • Others

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Retinitis Pigmentosa Treatment Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Rise in the Patients Suffering from Retinitis Pigmentosa to Aid the Retinitis Pigmentosa Treatment Industry Growth

The market for retinitis pigmentosa treatment is being driven by the rise in the patients suffering from retinitis pigmentosa across the globe. The market forces, such as rich product pipeline and increase in the funds for researchers developing new innovative drugs for the treatment of retinitis pigmentosa, are expected to aid the market growth of retinitis pigmentosa treatment over the forecast period. In addition, the rise in the special designation from the supervisory to offer a treatment to the patients as soon as possible is invigorating the market growth.

 

Key Industry Players in the Global Retinitis Pigmentosa Treatment Market

The report gives a detailed analysis of the following key players in the global retinitis pigmentosa treatment market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Ionis Pharmaceuticals, Inc.
  • Orphagen Pharmaceuticals, Inc.
  • ReNeuron Group plc
  • Ocugen, Inc.
  • MeiraGTx Limited.
  • Others

The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model along with giving a SWOT analysis.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Retinitis Pigmentosa Treatment Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Retinitis Pigmentosa Treatment Historical Market (2016-2020) 
    8.3    Global Retinitis Pigmentosa Treatment Market Forecast (2021-2026)
    8.4    Global Retinitis Pigmentosa Treatment Market by Type
        8.4.1    Autosomal Recessive RP
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2016-2020)
            8.4.1.3    Forecast Trend (2021-2026)
        8.4.2    Autosomal Dominant RP
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2016-2020)
            8.4.2.3    Forecast Trend (2021-2026)
        8.4.3    X-Linked RP
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2016-2020)
            8.4.3.3    Forecast Trend (2021-2026)
    8.5    Global Retinitis Pigmentosa Treatment Market by Treatment 
        8.5.1    Drug
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2016-2020)
            8.5.1.3    Forecast Trend (2021-2026)
            8.5.1.4    Breakup by Type
                8.5.1.4.1    Vitamin A Palmitate
                    8.5.1.4.1.1    Market Share
                    8.5.1.4.1.2    Historical Trend (2016-2020)
                    8.5.1.4.1.3    Forecast Trend (2021-2026)
                8.5.1.4.2    Acetazolamide
                    8.5.1.4.2.1    Market Share
                    8.5.1.4.2.2    Historical Trend (2016-2020)
                    8.5.1.4.2.3    Forecast Trend (2021-2026)
                8.5.1.4.3    Others
        8.5.2    Device
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2016-2020)
            8.5.2.3    Forecast Trend (2021-2026)
            8.5.2.4    Breakup by Type
                8.5.2.4.1    Sunglasses
                    8.5.2.4.1.1    Market Share
                    8.5.2.4.1.2    Historical Trend (2016-2020)
                    8.5.2.4.1.3    Forecast Trend (2021-2026)
                8.5.2.4.2    Implants
                    8.5.2.4.2.1    Market Share
                    8.5.2.4.2.2    Historical Trend (2016-2020)
                    8.5.2.4.2.3    Forecast Trend (2021-2026)
                8.5.2.4.3    Others
        8.5.3    Surgery
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2016-2020)
            8.5.3.3    Forecast Trend (2021-2026)
            8.5.3.4    Breakup by Type
                8.5.3.4.1    Retinal Transplantation
                    8.5.3.4.1.1    Market Share
                    8.5.3.4.1.2    Historical Trend (2016-2020)
                    8.5.3.4.1.3    Forecast Trend (2021-2026)
                8.5.3.4.2    Corneal Neurotization
                    8.5.3.4.2.1    Market Share
                    8.5.3.4.2.2    Historical Trend (2016-2020)
                    8.5.3.4.2.3    Forecast Trend (2021-2026)
                8.5.3.4.3    Others
    8.6    Global Retinitis Pigmentosa Treatment Market by Distribution Channel
        8.6.1    Hospital Retailer
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2016-2020)
            8.6.1.3    Forecast Trend (2021-2026)
        8.6.2    Retail Retailer
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2016-2020)
            8.6.2.3    Forecast Trend (2021-2026)
        8.6.3    Online
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2016-2020)
            8.6.3.3    Forecast Trend (2021-2026)
    8.7    Global Retinitis Pigmentosa Treatment Market by End Use
        8.7.1    Hospitals
            8.7.1.1    Market Share
            8.7.1.2    Historical Trend (2016-2020)
            8.7.1.3    Forecast Trend (2021-2026)
        8.7.2    Special Clinics
            8.7.2.1    Market Share
            8.7.2.2    Historical Trend (2016-2020)
            8.7.2.3    Forecast Trend (2021-2026)
        8.7.3    Home Care
            8.7.3.1    Market Share
            8.7.3.2    Historical Trend (2016-2020)
            8.7.3.3    Forecast Trend (2021-2026)
        8.7.4    Ophthalmologist
            8.7.4.1    Market Share
            8.7.4.2    Historical Trend (2016-2020)
            8.7.4.3    Forecast Trend (2021-2026)
        8.7.5    Others
    8.8    Global Retinitis Pigmentosa Treatment Market by Region
        8.8.1    Market Share
            8.8.1.1    North America
            8.8.1.2    Europe
            8.8.1.3    Asia Pacific
            8.8.1.4    Latin America
            8.8.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2016-2020)
        9.1.2    Forecast Trend (2021-2026)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2016-2020)
        9.2.2    Forecast Trend (2021-2026)
        9.2.3    Breakup by Country
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2016-2020)
        9.3.2    Forecast Trend (2021-2026)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2016-2020)
        9.4.2    Forecast Trend (2021-2026)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2016-2020)
        9.5.2    Forecast Trend (2021-2026)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    Ionis Pharmaceuticals, Inc.
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    Orphagen Pharmaceuticals, Inc.
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3    ReNeuron Group plc
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    Ocugen, Inc.
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    MeiraGTx Limited.
            12.2.5.1    Company Overview
            12.2.5.2    Product Portfolio
            12.2.5.3    Demographic Reach and Achievements
            12.2.5.4    Certifications
        12.2.6    Others
13    Industry Events and Developments


List of Figures and Tables

1.    Global Retinitis Pigmentosa Treatment Market: Key Industry Highlights, 2016 and 2026
2.    Global Retinitis Pigmentosa Treatment Historical Market: Breakup by Type (USD Billion), 2016-2020
3.    Global Retinitis Pigmentosa Treatment Market Forecast: Breakup by Type (USD Billion), 2021-2026
4.    Global Retinitis Pigmentosa Treatment Historical Market: Breakup by Treatment (USD Billion), 2016-2020
5.    Global Retinitis Pigmentosa Treatment Market Forecast: Breakup by Treatment (USD Billion), 2021-2026
6.    Global Retinitis Pigmentosa Treatment Historical Market: Breakup by Distribution Channel (USD Billion), 2016-2020
7.    Global Retinitis Pigmentosa Treatment Market Forecast: Breakup by Distribution Channel (USD Billion), 2021-2026
8.    Global Retinitis Pigmentosa Treatment Historical Market: Breakup by End Use (USD Billion), 2016-2020
9.    Global Retinitis Pigmentosa Treatment Market Forecast: Breakup by End Use (USD Billion), 2021-2026
10.    Global Retinitis Pigmentosa Treatment Historical Market: Breakup by Region (USD Billion), 2016-2020
11.    Global Retinitis Pigmentosa Treatment Market Forecast: Breakup by Region (USD Billion), 2021-2026
12.    North America Retinitis Pigmentosa Treatment Historical Market: Breakup by Country (USD Billion), 2016-2020
13.    North America Retinitis Pigmentosa Treatment Market Forecast: Breakup by Country (USD Billion), 2021-2026
14.    Europe Retinitis Pigmentosa Treatment Historical Market: Breakup by Country (USD Billion), 2016-2020
15.    Europe Retinitis Pigmentosa Treatment Market Forecast: Breakup by Country (USD Billion), 2021-2026
16.    Asia Pacific Retinitis Pigmentosa Treatment Historical Market: Breakup by Country (USD Billion), 2016-2020
17.    Asia Pacific Retinitis Pigmentosa Treatment Market Forecast: Breakup by Country (USD Billion), 2021-2026
18.    Latin America Retinitis Pigmentosa Treatment Historical Market: Breakup by Country (USD Billion), 2016-2020
19.    Latin America Retinitis Pigmentosa Treatment Market Forecast: Breakup by Country (USD Billion), 2021-2026
20.    Middle East and Africa Retinitis Pigmentosa Treatment Historical Market: Breakup by Country (USD Billion), 2016-2020
21.    Middle East and Africa Retinitis Pigmentosa Treatment Market Forecast: Breakup by Country (USD Billion), 2021-2026
22.    Global Retinitis Pigmentosa Treatment Market Structure

Key Questions Answered in the Report

The global retinitis pigmentosa treatment market is being driven by the rising retinal disorder treatment market, which is projected to grow at a CAGR of 7% between 2020 and 2025.

The global retinal disorder treatment market is estimated to reach about USD 15.4 billion by 2025 and is expected to continue to support the growth of the retinitis pigmentosa treatment industry.

The major drivers of the industry, such as the surge in the number of research and awareness regarding the disorder, greater affordability, rise in product offerings, and an increase in demand for early treatment, are expected to aid the market growth.

The key trend guiding the growth of the market includes the increase in the funds for researchers developing new innovative drugs for the treatment of retinitis pigmentosa.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The significant types of retinitis pigmentosa treatment in the market are autosomal recessive RP, autosomal dominant RP, and X-linked RP.

The treatments of retinitis pigmentosa include drug, device, and surgery.

The major distribution channel in the industry are hospital retailer, retail retailer, and online.

The leading end use sectors in the market are hospitals, special clinics, home care, and ophthalmologist, among others.

The major players in the industry are Ionis Pharmaceuticals, Inc., Orphagen Pharmaceuticals, Inc., ReNeuron Group plc, Ocugen, Inc., and MeiraGTx Limited., among others.

Analyst Review

The global retinitis pigmentosa treatment market is being driven by the rising research in the industry and the growing retinal disorder treatment market. Aided by the rising investments into drug development, the retinal disorder treatment market is expected to witness a healthy growth in the forecast period of 2020-2025, growing at a CAGR of 7%. The retinal disorder treatment industry is projected to reach USD 15.4 billion by 2025.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on type, the market is segmented into autosomal recessive RP, autosomal dominant RP, and X-linked RP. On the basis of treatment, the industry is divided into drug, device, and surgery. By distribution channel, the industry is segmented into hospital retailer, retail retailer, and online. Based on end use, the market is divided into hospitals, special clinics, home care, and ophthalmologist, among others. The major regional markets for retinitis pigmentosa treatment are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Ionis Pharmaceuticals, Inc., Orphagen Pharmaceuticals, Inc., ReNeuron Group plc, Ocugen, Inc., and MeiraGTx Limited., among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$ 1999     $1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • Free Update in 180 Days

Single User License

$ 3099     $2499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • Free Update in 180 Days

Five User License

$ 4099     $3499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • Free Update in 180 Days

Corporate License

$ 5099     $4499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • Free Update in 180 Days

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports

Global Giant Cell Arteritis Treatment Market Report and Forecast 2021-2026


Global Alternative Cancer Treatment Market Report and Forecast 2021-2026


Global Atrophic Scar Treatment Market Report and Forecast 2021-2026


Global Emphysema Treatment Market Report and Forecast 2021-2026



NEWSLETTER